2-Chlorodeoxyadenosine and cytarabine co
✍
Elias Jabbour; Srdan Verstovsek; Francis Giles; Varsha Gandhi; Jorge Cortes; Sus
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 81 KB
👁 1 views
## Abstract ## BACKGROUND Hypereosinophilic syndrome (HES) is a rare, disabling, and incurable disease. In this study, a combination of 2‐chlorodeoxyadenosine (2‐CdA) and cytosine arabinoside (ara‐C) chemotherapy was evaluated in patients with HES. ## METHODS Nine patients with HES were treated